Status:
ACTIVE_NOT_RECRUITING
Elderly With Locally Advanced Lung Cancer: Deciding Through Geriatric Assessment on the Optimal Treatment Strategy
Lead Sponsor:
Maastricht Radiation Oncology
Collaborating Sponsors:
Dutch Society of Physicians for Pulmonology and Tuberculosis
Erasmus Medical Center
Conditions:
NSCLC
Eligibility:
All Genders
75+ years
Brief Summary
There is no detailed information available on benefits and harms of intensified treatment with concurrent RCHT among a subpopulation of elderly patients. Reliable tools are needed to distinguish the s...
Detailed Description
Lung cancer is a problem of the elderly: 30% of the lung cancer patients are aged ≥ 75 years. Due to underrepresentation of elderly patients in clinical trials there is a lack of evidence to select th...
Eligibility Criteria
Inclusion
- Inclusion criteria (according to the protocol):
- Any subtype of pathologically proven NSCLC, primary UICC Stage III disease;
- Age ≥ 75 years;
- No surgery or adjuvant chemotherapy for NSCLC in the last year;
- No prior radiotherapy to the ipsilateral thorax or mediastinum;
- No clinical superior vena cava syndrome;
- No diagnosis of other cancer within the last 3-years (except in situ carcinoma's and / or non-melanoma skin cancer);
- Written informed consent
Exclusion
Key Trial Info
Start Date :
July 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 18 2029
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT02284308
Start Date
July 1 2016
End Date
December 18 2029
Last Update
July 4 2025
Active Locations (22)
Enter a location and click search to find clinical trials sorted by distance.
1
Ziekenhuisgroep Twente
Almelo, Netherlands, 7609 PP
2
Gelre ziekenhuis
Apeldoorn, Netherlands, 7334 DZ
3
Radiotherapiegroep Arnhem
Arnhem, Netherlands, 6815 AD
4
Rijnstate
Arnhem, Netherlands, 6815 AD